News

This is the first version of abacavir/lamivudine with scoring to allow for dose adjustment and is also flavored. The FDA’s tentative approval through the President’s Emergency Plan for

MRIGlobal will lead a team that will produce the vaccine to be used in a Phase I clinical trial. HPV can cause genital warts and cancer; it is

The grants will support researchers seeking to answer important questions about the virus’s fundamental nature, how it interacts with other substances, how it spreads, and how communication and

The acquired site, through its enhanced manufacturing capabilities, will help Johnson to meet increasing demand for custom pharmaceutical services and active ingredients. Johnson Matthey fine chemicals division director

GNbAC1 is said to be the first drug being developed to address a causal factor of the disease, and holds the potential to radically change the way MS

As part of an ongoing trial at the Jenner Institute at Oxford University, all the adult volunteers were earlier administered an experimental Ebola vaccine being developed by GSK

Novartis had been granted exclusive license in 2010, to develop and commercialize binimetinib. Designed specifically for cancer patients, the binimetinib is currently advancing in three Phase 3 clinical

Financial terms of the transaction were not disclosed by both the companies, however, sources familiar with the development have been cited by Reuters as saying that the deal

BAY 81-8973 is a full-length recombinant factor VIII which has demonstrated clinical evidence of efficacy when used for prophylaxis twice or three times per week, with standard dosages.